Siemens wins FDA clearance for Magnetom Open MRI scanner

Article

FDA finishes device review in four monthsMedical imaging vendors are enjoying a rare burst of productivityfrom Food and Drug Administration product reviewers, who havebeen granting marketing clearance to imaging devices at a frenziedpace this

FDA finishes device review in four months

Medical imaging vendors are enjoying a rare burst of productivityfrom Food and Drug Administration product reviewers, who havebeen granting marketing clearance to imaging devices at a frenziedpace this year. The latest winner in the device review lotteryis Siemens Medical Systems. The German vendor received word lastmonth of FDA clearance for Magnetom Open, a 0.2-tesla scannercapable of interventional MRI procedures. The FDA's action cameonly four months after Open's 510(k) application was filed.

Magnetom Open was introduced at the Radiological Society ofNorth America meeting last year (SCAN 11/17/93). The system, whichemploys resistive magnet technology and actively shielded gradients,is shaped like a giant C-arm to give clinicians access to patients.

Siemens hopes to use Open to forge new ground in interventionalMRI, but has plans for the scanner beyond this still-emergingniche. The vendor will also market Open as a cost-effective systemthat can pay for itself with traditional MRI procedures whileclinicians explore the utility of interventional scanning. Siemensplans to set the unit's list price under $1 million.

One of Magnetom Open's beta sites will be the newly formedCenter for Interventional MRI at the University of Californiaat Los Angeles. There, clinicians will use Open for MRI-guidedradio-frequency thermal ablation of primary and metastatic braintumors (SCAN 3/2/94).

Siemens competitor GE Medical Systems is also developing aninterventional MRI scanner, Signa MRT. The system has a superconducting0.5-tesla magnet in a "double doughnut" shape to facilitateaccess to the patient. Unlike Open, the GE system will be dedicatedto interventional procedures.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.